Survivors of Hodgkin's lymphoma (HL) frequently have many years to experience the long‐
term toxicities of combined modality therapies. Also, a significant proportion of HL patients …

Lymphocyte-Depleted Classical Hodgkin’s Lymphoma: A Comprehensive Analysis From the
German Hodgkin Study Group Page 1 Lymphocyte-Depleted Classical Hodgkin’s Lymphoma …

Simple Summary Classic Hodgkin lymphoma (CHL) is a well-defined lymphoid neoplasm
with a minority of characteristic neoplastic cells of B cell origin, namely Hodgkin and Reed …

Abstract The neoplastic Reed–Sternberg cells characteristic of classical Hodgkin's
lymphoma (cHL) are of B‐cell origin but they almost always show striking loss of a range of …

Hodgkin and Reed-Sternberg (HRS) cells in classical Hodgkin lymphoma (HL) and
lymphocytic and histiocytic (L&H) cells in nodular lymphocyte–predominant HL (NLPHL) are …

Abstract The Epstein‐Barr virus (EBV) is associated with a proportion of Hodgkin lymphoma
(HL) cases, and this association is believed to be causal. The aetiology of cases lacking …

Hodgkin lymphoma (HL) is classified into 2 largely distinct subgroups, namely nodular
lymphocyte predominant HL (NLPHL) and classic HL (CHL). CHL is further divided into …

Classic Hodgkin's lymphoma is characterised by Hodgkin and Reed-Sternberg cells and in
most cases are derived from germinal-centre B cells. Despite progress in basic research …

Hodgkin's lymphoma was first described in 1832, but the nature of the pathognomic Reed-
Sternberg cell, on which diagnosis of the disease is based, has only been elucidated in the …

Disease overview: Hodgkin lymphoma (HL) is an uncommon B-cell lymphoid malignancy
affecting 9,000 new patients annually and representing approximately 11% of all …